CRKL

protein-coding

CRK like proto-oncogene, adaptor protein, the group of SH2 domain containing

Gene summary

This gene encodes a protein kinase containing SH2 and SH3 (src homology) domains which has been shown to activate the RAS and JUN kinase signaling pathways and transform fibroblasts in a RAS-dependent fashion. It is a substrate of the BCR-ABL tyrosine kinase, plays a role in fibroblast transformation by BCR-ABL, and may be oncogenic.[provided by RefSeq, Jan 2009]

MANE transcript

NM_005207.4

Inheritance

—

ClinVar variants

U:25B:27

Top phenotype

CRKL-related disorder

gnomAD constraint

pLI —, LoF o/e 0.2

Max pathogenic AF

—

Genomic locus

chr22:20,917,407-20,953,747

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~36.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital heart diseaseNO_KNOWN

Inheritance Pattern: Unknown

Disease ID:MONDO:0005453

Submitter: ClinGen

*CRKL* was first reported in relation to congenital heart disease in 2012 (Tomita Mitchell et al., PMID:22318994). Seven probands with CNVs (4 duplications, 3 gross deletions) at the 22q11.2 location have been reported in 3 publications (PMID: 22318994, 28121514, 36205932). No evidence for a causal role for *CRKL* in congenital heart disease has been reported. Although this gene-disease association is supported by an animal model, no reports have directly implicated the gene in humans. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 10/17/2023 (SOP Version 9)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CRKL variants in ClinVar

3 Conditions Cataloged
not providedTotal: 41
not specifiedTotal: 23
CRKL-related disorderTotal: 8

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005207.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
25
clinvar
1
clinvar
26
missense
22
clinvar
1
clinvar
23
nonsense
0
start loss
0
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total002525252
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 7 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005207.4RefSeqNP_005198.13MANE Select
ENST00000354336.8EnsemblENSP00000346300.33MANE Select
ENST00000411769.1EnsemblENSP00000396646.13Standard
ENST00000894699.1EnsemblENSP00000564758.13Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
crklDanio rerio

Structure: fast muscle cell

Quality: mononucleate

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Chronic myeloid leukemia - Homo sapiens (human)
  • Focal adhesion - Homo sapiens (human)
  • Fc gamma R-mediated phagocytosis - Homo sapiens (human)
  • Renal cell carcinoma - Homo sapiens (human)
  • Neurotrophin signaling pathway - Homo sapiens (human)

Biological Process

  • activation of MAPKK activity
  • activation of MAPK activity
  • regulation of cell growth
  • blood vessel development
  • urogenital system development

Molecular Function

  • phosphotyrosine residue binding
  • RNA binding
  • SH3/SH2 adaptor activity
  • protein binding
  • identical protein binding

Cellular Component

  • nucleoplasm
  • cytosol
  • neuromuscular junction
  • protein-containing complex
  • extrinsic component of postsynaptic membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000354336
Coding exons
3
Length
36324
Individuals with no LoFs
125740
Homozygous LoFs
0
Heterozygous LoFs
4
Defined
125744
p
0.0000159
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.941051780.5910.000009431973
Missense (PolyPhen)2368.1770.33736767
Synonymous-2.039875.61.300.00000447633
Loss of Function2.3129.820.2044.23e-7118

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian0.0000540.000054rare
Finnish00.0absent
European (Non-Finnish)0.0000270.000026rare
South Asian00.0absent
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: May mediate the transduction of intracellular signals.;

Recessive Scores

pRec
0.440

Intolerance Scores

LoFtool
0.0613
RVIS EVS
-0.32
RVIS percentile EVS
31.46

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
E
Essential (gene trap)
H
Indispensability pred.
E
Indispensability score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.